Columbia Mailman School of Public Health  The Dean's Grand Rounds on the Future of Public Health  Gary S. Belkin, MD, PhD, MPH Founder, Billion Minds Institute Former NYC Deputy Health Commissioner 2020-2021 McSilver Fellow-in-Residence McSilver Institute for Poverty Policy and Research at New York University Kathleen J. Sikkema, PhD Chair and Stephen Smith Professor  Department of Sociomedical Sciences Columbia Mailman School of Public Health Linda P. Fried, MD, MPH (moderator) Dean, Columbia Mailman School of Public Health DeLamar Professor of Public Health Practice Professor, Epidemiology and Medicine Senior Vice President, Columbia University Medical Center Initiated in 2008, Grand Rounds is a community conversation on the science, education, and practice of public health. The series provides an intellectual space within which to explore national and global public health challenges and the innovative approaches needed to transform the public’s health in the 21st century. COVID-19 has served as a magnifying glass on a broken, structurally racist and unequal health system which falls grievously short of protecting communities of color, the aged and the vulnerable.  It also has highlighted the devastating consequences of our country’s absence of a public health system charged with protecting and elevating health for all.  This year we will deepen our understanding, research, teaching and action on this topic, through our Grand Rounds on the Future of Public Health Series. All events are open to the public. For questions or more information, please contact Lauren Sagnella.  Columbia University makes every effort to accommodate individuals with disabilities. Please notify the office at least 10 days in advance if you require closed captioning, sign-language interpretation or any other disability accommodations. Alternatively, Disability Services can be reached at 212.854.2388 and disability@columbia.edu. 

Challenges in Management of Bladder and Prostate Cancer in 2021: What Happens When the Standard of Care is Not Enough?  This symposium will focus on updating practitioners on recent developments in the management of high risk localized prostate cancer, BCG unresponsive nonmusclei invasive bladder cancer as well as the multidisciplinary management of muscle invasive bladder cancer. These updates will include descriptions of the epidemiology of these entities as well as recently published data describing innovative ways of managing these three clinical disease states. A particular focus will be placed on ongoing clinical trials available at Columbia University’s Herbert Irving Cancer Center. The target audience of this seminar will include practicing Urologists, medical oncologists, radiation oncologists, nurse practitioners, and trainees interested in prostate and bladder cancer care. Upon conclusion of this activity, participants will be better able to: 1. Recognize high risk localized prostate cancer and its treatment options including surgery, radiation, and neoadjuvant systemic therapies. 2. Define the disease state known as BCG unresponsive bladder cancer and review the available FDA approved as well as clinical trial therapies in this space. 3. Describe the results of neoadjuvant chemotherapy for muscle invasive bladder cancer and elaborate on the role of systemic immunotherapy in this setting. FACULTY Christopher B. Anderson, MD, MPH Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Guarionex Joel Decastro, MD, MPH, Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY James M. McKiernan, MD, John K. Lattimer Professor of Urology; Director, Urologic Oncology; Chair, Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Catherine S. Spina, MD, PhD, Assistant Professor of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Mark N. Stein, MD, Associate Professor of Medical Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY AGENDA 5:00 PM Welcome James M. McKiernan, MD 5:05 PM High Risk Localized Prostate Cancer: Updates in Multidisciplinary Care Christopher B. Anderson, MD, MPH & Catherine S. Spina, MD, PhD 5:25 PM BCG Unresponsive High Risk Non-Muscle Invasive Bladder Cancer: An Expanding Menus of Options Guarionex Joel Decastro, MD, MPH 5:45 PM Muscle Invasive Bladder Cancer: It’s Not Just Cystectomy Anymore Mark N. Stein, MD 6:05 PM Q&A 6:30 PM Adjourn This activity has been approved for AMA PRA Category 1 Credit™

Simon K. Cheng, MD, PhD, Residency Program Director and Assistant Professor of Radiation Oncology Naiyer A. Rizvi, MD, Professor of Medicine at CUMC Catherine A. Shu, MD, Professor of Medicine at CUMC Joshua R. Sonett, MD, Edward C. and Anne K. Weiskopf Professor of Surgical Oncology (in Surgery) at CUMC This activity has been approved for AMA PRA Category 1 Credit™

People with psychiatric disorders may have cognitive impairments that affect their ability to function in daily life, and benefit from psychiatric interventions. Cognitive skills training directly targets impaired cognitive processes seen across a variety of psychiatric conditions and thereby seeks to improve behavioral functioning. This conference will provide a forum for academic researchers, clinicians, and students to learn about evidence-based cognitive interventions. Research symposia will spotlight novel treatment approaches and inform key issues pertinent to treatment implementation and effectiveness. A clinical workshop will provide expert guidance in translating evidence-based cognitive remediation approaches for virtual delivery. Upcon conclusion of the activity, participants will be better able to: 1. Identify cognitive deficits, motivation deficits that interact with cognitive deficits, and how both can be targeted in recovery-oriented treatments for people with psychiatric disorders 2. Identify integrative intervention approaches to improve cognitive health, mental health, and functional outcomes in people with psychiatric disorders 3. Summarize factors that impact engagement in cognitive treatments and potential strategies to facilitate motivation and cognitive learning 4. Describe challenges to implementing empirically based cognitive interventions in routine settings and approaches to overcome them 5. Summarize how to provide remote cognitive health care